dementia : 1 Commons debate
===========================
Opposition Day: [Un-allotted Half Day] - Future Government Spending (4 Mar 2015)
http://www.theyworkforyou.com/debates/?id=2015-03-04a.989.1&s=dementia#g1029.1
Oliver Colvile: ...about the importance of our controlling public
expenditure. Over the past five years, I have worked closely with
Plymouth university's Ian Sherriff on long-term care for the elderly and
combating *dementia*, which is something I know my right hon. Friend the
Prime Minister takes very seriously. For those in our mid-50s and facing
old age, the worry is that we will get *dementia*, so I...
dementia : 1 Written Answer
===========================
Written Answers - Department of Health: Alliance Medical (4 Mar 2015)
http://www.theyworkforyou.com/wrans/?id=2015-02-27.225738.h&s=dementia#g225738.r0
Jane Ellison: ...and - a substantial number of PET-CT scans at no
additional cost to support the research and clinical trials capability
of the national network, not only in cancer, but also in new
applications such as *dementia*, to provide the evidence needed to
develop and enhance services for patients.
===========================
Opposition Day: [Un-allotted Half Day] - Future Government Spending (4 Mar 2015)
http://www.theyworkforyou.com/debates/?id=2015-03-04a.989.1&s=dementia#g1029.1
Oliver Colvile: ...about the importance of our controlling public
expenditure. Over the past five years, I have worked closely with
Plymouth university's Ian Sherriff on long-term care for the elderly and
combating *dementia*, which is something I know my right hon. Friend the
Prime Minister takes very seriously. For those in our mid-50s and facing
old age, the worry is that we will get *dementia*, so I...
dementia : 1 Written Answer
===========================
Written Answers - Department of Health: Alliance Medical (4 Mar 2015)
http://www.theyworkforyou.com/wrans/?id=2015-02-27.225738.h&s=dementia#g225738.r0
Jane Ellison: ...and - a substantial number of PET-CT scans at no
additional cost to support the research and clinical trials capability
of the national network, not only in cancer, but also in new
applications such as *dementia*, to provide the evidence needed to
develop and enhance services for patients.
